Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
Show more...
FAQ
Bristol-Myers Squibb Company PFD CONV 2 今天的股价是多少?▼
BMYMP 当前价格为 $400.00 USD,在过去 24 小时内下跌了 -48.75%。在图表上更密切关注 Bristol-Myers Squibb Company PFD CONV 2 股票的表现。
Bristol-Myers Squibb Company PFD CONV 2 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 OTCM 交易所,Bristol-Myers Squibb Company PFD CONV 2 的股票以代码 BMYMP 进行交易。
Bristol-Myers Squibb Company PFD CONV 2 的股价在上涨吗?▼
BMYMP 股票较上周上涨 +0%,本月上涨 +0%,但过去一年 Bristol-Myers Squibb Company PFD CONV 2 下跌 -50.03%。
Bristol-Myers Squibb Company PFD CONV 2 的市值是多少?▼
今天 Bristol-Myers Squibb Company PFD CONV 2 的市值为 814.59B
Bristol-Myers Squibb Company PFD CONV 2 去年的营收是多少?▼
Bristol-Myers Squibb Company PFD CONV 2 去年的营收为 96.39BUSD。
Bristol-Myers Squibb Company PFD CONV 2 去年的净利润是多少?▼
BMYMP 去年的净收益为 14.11BUSD。
Bristol-Myers Squibb Company PFD CONV 2 会发放股息吗?▼
是的,BMYMP 的股息每 每季度 发放一次。每股最新股息为 0.5 USD。截至今日,股息率(FWD)% 为 0.5%。
Bristol-Myers Squibb Company PFD CONV 2 有多少名员工?▼
截至九月 04, 2026,公司共有34,100名员工。
Bristol-Myers Squibb Company PFD CONV 2 属于哪个行业?▼
Bristol-Myers Squibb Company PFD CONV 2从事于其他行业。
Bristol-Myers Squibb Company PFD CONV 2 何时完成拆股?▼
Bristol-Myers Squibb Company PFD CONV 2 最近没有进行任何拆股。